Physiologically based pharmacokinetic (PBPK) modeling simulates dynamic physiological factors impacting oral performance, and when coupled with in vitro testing and experience in addressing key formulation challenges such as bioavailability, has proven effective in applications throughout the drug development cycle. Read the technical brief to discover more about our industry-leading expertise and track record in addressing dissolution and solubility challenges, how we quickly and accurately determine the appropriate technology and our formulation approach to best ensure early development success.
You may also be interested in:
View our technical brief
Latest content
Latest briefing from the Knowledge Center